Literature DB >> 15785313

Modifying effects of Terminalia catappa on azoxymethane-induced colon carcinogenesis in male F344 rats.

T Morioka1, M Suzui, V Nabandith, M Inamine, Y Aniya, T Nakayama, T Ichiba, N Yoshimi.   

Abstract

The modifying effects of dietary administration of an herb, Terminalia catappa (TC), were investigated on rat colon carcinogenesis induced by a carcinogen azoxymethane (AOM). The number of aberrant crypt foci (ACF) and beta-catenin accumulated crypts (BCACs) in the colon, and proliferating cell nuclear antigen (PCNA) labelling index in the colonic epithelium were examined in a total of 36 male F344 rats. All animals were randomly divided into five experimental groups (4-10 rats in each group). At 6 weeks of age, rats in groups 1, 2 and 3 were given s.c. injections of AOM once a week for 2 weeks at a concentration of 20 mg/kg body weight. One week before the first injection of AOM, rats in groups 2 and 3 were fed a diet containing 0.02 and 0.1% TC, respectively, throughout the experiment. Rats in group 4 were fed a diet containing 0.1% TC. Rats in group 5 were served as untreated controls. All animals were sacrificed at the experimental week 5 after the start of the experiment. Oral administration of TC at both doses significantly decreased the numbers of both ACF/colon/rat (P<0.05 for 0.02% TC, P<0.005 for 0.1% TC) and BCAC/cm/rat (P<0.05 for both 0.02 and 0.1% TC), when compared with the control group (group 1). Colonic PCNA labelling index in groups 2 and 3 was also significantly lower than that in group 1 (P<0.001 for 0.02% TC, P<0.005 for 0.1% TC). These results suggest that TC has a potent short-term chemopreventive effect on biomarkers of colon carcinogenesis and this effect may be associated with the inhibition of the development of ACF and BCACs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15785313     DOI: 10.1097/00008469-200504000-00005

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  8 in total

Review 1.  An updated review of Terminalia catappa.

Authors:  Arumugam Vijaya Anand; Natarajan Divya; Pannerselvam Punniya Kotti
Journal:  Pharmacogn Rev       Date:  2015 Jul-Dec

2.  Dietary-feeding of grape seed extract prevents azoxymethane-induced colonic aberrant crypt foci formation in fischer 344 rats.

Authors:  Balaiya Velmurugan; Rana P Singh; Rajesh Agarwal; Chapla Agarwal
Journal:  Mol Carcinog       Date:  2010-07       Impact factor: 4.784

3.  Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-κB and AP-1 Activity.

Authors:  Chao-Bin Yeh; Ming-Ju Hsieh; Yih-Shou Hsieh; Ming-Hsien Chien; Pen-Yuan Lin; Hui-Ling Chiou; Shun-Fa Yang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-08       Impact factor: 2.629

Review 4.  Exploration of Phytochemicals Found in Terminalia sp. and their Antiretroviral Activities.

Authors:  Alka Dwevedi; Raman Dwivedi; Yogesh K Sharma
Journal:  Pharmacogn Rev       Date:  2016 Jul-Dec

Review 5.  Development of bioresources in Okinawa: understanding the multiple targeted actions of antioxidant phytochemicals.

Authors:  Yoko Aniya
Journal:  J Toxicol Pathol       Date:  2018-08-13       Impact factor: 1.628

6.  Extracts of Musa basjoo induce growth inhibition and changes in the protein expression of cell cycle control molecules in human colorectal cancer cell lines.

Authors:  Harutoshi Matsumoto; Saeko Ando; Eri Yoshimoto; Takamasa Numano; Nahida Sultana; Katsumi Fukamachi; Munekazu Iinuma; Kensuke Okuda; Kazunori Kimura; Masumi Suzui
Journal:  Oncol Lett       Date:  2022-01-27       Impact factor: 2.967

Review 7.  Colon preneoplastic lesions in animal models.

Authors:  Masumi Suzui; Takamitsu Morioka; Naoki Yoshimi
Journal:  J Toxicol Pathol       Date:  2013-12-26       Impact factor: 1.628

8.  Characterization and Quantification of Compounds in the Hydroalcoholic Extract of the Leaves from Terminalia catappa Linn. (Combretaceae) and Their Mutagenic Activity.

Authors:  Francisco José Mininel; Carlos Sérgio Leonardo Junior; Lívia Greghi Espanha; Flávia Aparecida Resende; Eliana Aparecida Varanda; Clarice Queico Fujimura Leite; Wagner Vilegas; Lourdes Campaner Dos Santos
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-09       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.